MedTrace Logo

Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis

NCT02640391 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 127

Last updated 2019-08-13

No results posted yet for this study

Summary

The purpose of this study is to determine whether fecal calprotectin, fecal immunochemical test, and Rome III criteria for irritable bowel syndrome (IBS) can predict mucosal healing in patients with quiescent ulcerative colitis (UC).

Conditions

Interventions

OTHER

colonoscopy

Sponsors & Collaborators

  • Kyungpook National University Hospital

    lead OTHER

Principal Investigators

  • Eun Soo Kim, MD, PhD · Keimyung University School of Medicine

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02640391 on ClinicalTrials.gov